Trapidil (triazolopyrimidine), a platelet-derived growth factor antagonist, reduces restenosis after percutaneous transluminal coronary angioplasty. Results of the randomized, double-blind STARC study. Studio Trapidil versus Aspirin nella Restenosi C
(Q57479764)
scientific article published on 01 December 1994
scientific article published on 01 December 1994
Language:
other details
description | scientific article published on 01 December 1994 |
External Links
(P356) |
10.1161/01.CIR.90.6.2710
|
(P698) |
7994812
|